Predictive Protocol Intelligence & Synthetic Control Architecture
Physician-Led. Deep Tech Powered. Simulating the Future of Clinical Success.
MedSciConnect transforms traditional clinical trial architecture using Protocol Intelligence, Synthetic Control Arms, and AI-driven predictive clinical simulation.
- Pre-Seed · Deep-Tech Biotech
Protocol Intelligence
Multivariate feasibility simulation on draft protocols.
Synthetic Control Arms
High-fidelity Digital Twins via Generative AI.
Predictive Simulation
AI-driven enrollment & outcome forecasting.
- The Clinical Efficacy Gap
Trials fail because they are designed in a vacuum.
“Traditional clinical trials fail because they are designed in a vacuum. 80% of trials experience significant delays — not because patients don’t exist, but because protocol architecture is fundamentally disconnected from real-world biological data.”
Recruitment Paradox
Patients exist — but rigid criteria block the right matches.
Placebo Ethics Dilemma
Live placebo arms raise mounting ethical and regulatory friction.
Phase II/III Enrollment Failures
Late-stage trials stall when protocol design ignores biology.
Billions Lost in R&D Capitalization
Late-stage trials stall when protocol design ignores biology.
- Layer 01
Protocol Intelligence (PI) Layer
“Our algorithm ingests draft protocols and performs a Multivariate Feasibility Simulation. It identifies ‘Screen Failure Triggers’ — criteria that are scientifically sound but statistically catastrophic for enrollment.”
Graph Neural Networks (GNN)
Modeling biological & operational dependencies across protocol variables.
Patient Eligibility Quotient (PEQ)
Quantified score for protocol-fit against real-world patient populations.
Sensitivity Heatmap
Visualize which criteria are statistically catastrophic for enrollment.
Predictive Protocol Optimization
Iterative AI refinement before a single patient is screened.
- Layer 01
Protocol Intelligence (PI) Layer
“Our algorithm ingests draft protocols and performs a Multivariate Feasibility Simulation. It identifies ‘Screen Failure Triggers’ — criteria that are scientifically sound but statistically catastrophic for enrollment.”
“We utilize Generative AI to create high-fidelity ‘Digital Twins,’ reducing the requirement for live placebo patients by up to 50% while maintaining regulatory-grade statistical power.”
- Real-World Data (RWD)
- Variational Autoencoders (VAEs)
- Digital Twins
- Propensity Score Matching (PSM)
- FDA / EMA External Control Validity
SCA Engine
Live Simulation
- Therapeutic Focus
Where precision compounds value
Immunology
Complex immune-mediated indications.
Rare Disease
Small populations, high signal precision.
Hyper-Targeted Protocol Design
Late-stage trials stall when protocol design ignores biology.
AI-Driven Patient Response Prediction
Forecasting outcomes before enrollment.
Ultra-Orphan Indication Positioning
Strategic edge in underserved markets.
- Business Model
High-margin Bio-SaaS positioning
- PaaS
Protocol Optimization License
Cloud-based access to the Protocol Intelligence Layer for Clinical Operations and R&D teams.
- Multivariate feasibility simulation
- PEQ scoring & sensitivity heatmaps
- Iterative protocol optimization
- Enterprise
- Flagship
Full SCA Generation & Regulatory Submission Support
End-to-end Synthetic Control Arm generation with regulatory-grade validation and submission support.
- Digital Twin cohort generation
- PSM & RWD integration
- FDA / EMA submission packages
The Product: A Cloud-based Platform-as-a-Service (PaaS) for Clinical Operations and R&D teams.
High-margin Bio-SaaS positioning
Target 85% Gross Margin
- Call to Action
Strategischen Zugang sichern, bevor der Markt es einpreist
Kostenlosen Investment-Report sichern
Trag dich ein und erhalte den Report „Die nächsten 10x Märkte” direkt in dein Postfach.
- Mit dem Klick stimmst du unserer Datenschutzerklärung zu.